经肝动脉化疗栓塞术联合冷循环微波刀治疗肝癌的临床研究  

Research on clinical effect observation of TACE combined with percutaneous microwave coagulation therapy on treatment of patients with hepatocellular carcinoma

作　　者：李彬[1] 孙超[1] 段惠勇[1] 

机构地区：[1]南阳市第一人民医院放射科,河南南阳473001

出　　处：《中国医学装备》2015年第12期137-139,共3页China Medical Equipment

摘　　要：目的:研究经肝动脉化疗栓塞术(TACE)联合冷循环微波刀(PMCT)治疗肝癌的临床效果。方法:分析TACE联合PMCT治疗的60例肝癌患者临床资料。结果:患者均顺利完成手术,未出现严重并发症以及死亡事件。近期疗效显示:完全缓解(CR)4例,部分缓解(R)38例,无变化(SD)16例,进展(PD)2例,治疗总有效率为70.0%;术后1年、2年及3年生存例数(比率)分别为:46例(占76.7%)、35例(占58.3%)、31例(占51.7%);术后血清甲胎蛋白(AFP)水平降低明显;肝功能明显改善;病灶直径明显减小。结论:TACE联合PMCT是治疗肝癌的有效手段。Objective： To explore the effect of transcatheter arterial chemoembolization（TACE） combined with percutaneous microwave coagulation therapy（PMCT） on treatment of patients with hepatic carcinoma. Methods： The clinical data of 60 cases of liver cancer patients in our hospital in TACE combined with PMCT were analyzed. Results： The operation was successfully performed, no serious complications and death. Efficacy： 4 CR cases, 38 PR cases, 16 SD cases, 2 PD cases, the total efficiency of treatment was 70.0%; After 1, 2, 3 year, survival cases（ratio） were respectively： 46（76.7%）, 35（58.3%）, 31（51.7%）; The levels of Serum alpha fetoprotein（AFP） after operation was significantly reduced, after treatment, the patient＇s liver function improved significantly; The diameter of the lesions was significantly reduced. Conclusion： TACE combined with PMCT is an effective therapy for hepatic carcinoma.

关 键 词：经肝动脉化疗栓塞术 冷循环微波刀 肝癌 

分 类 号：R735.7[医药卫生—肿瘤]